Literature DB >> 21724843

Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.

François Béliveau1, Cédric Brulé, Antoine Désilets, Brandon Zimmerman, Stéphane A Laporte, Christine L Lavoie, Richard Leduc.   

Abstract

The type II transmembrane serine protease TMPRSS6 (also known as matriptase-2) controls iron homeostasis through its negative regulation of expression of hepcidin, a key hormone involved in iron metabolism. Upstream of the hepcidin-regulated signaling pathway, TMPRSS6 cleaves its target substrate hemojuvelin (HJV) at the plasma membrane, but the dynamics of the cell-surface expression of the protease have not been addressed. Here, we report that TMPRSS6 undergoes constitutive internalization in transfected HEK293 cells and in two human hepatic cell lines, HepG2 and primary hepatocytes, both of which express TMPRSS6 endogenously. Cell surface-labeled TMPRSS6 was internalized and was detected in clathrin- and AP-2-positive vesicles via a dynamin-dependent pathway. The endocytosed TMPRSS6 next transited in early endosomes and then to lysosomes. Internalization of TMPRSS6 is dependent on specific residues within its N-terminal cytoplasmic domain, as site-directed mutagenesis of these residues abrogated internalization and maintained the enzyme at the cell surface. Cells coexpressing these mutants and HJV produced significantly decreased levels of hepcidin compared with wild-type TMPRSS6 due to the sustained cleavage of HJV at the cell surface by TMPRSS6 mutants. Our results underscore for the first time the importance of TMPRSS6 trafficking at the plasma membrane in the regulation of hepcidin expression, an event that is essential for iron homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21724843      PMCID: PMC3190711          DOI: 10.1074/jbc.M111.223461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.

Authors:  Jodie L Babitt; Franklin W Huang; Diedra M Wrighting; Yin Xia; Yisrael Sidis; Tarek A Samad; Jason A Campagna; Raymond T Chung; Alan L Schneyer; Clifford J Woolf; Nancy C Andrews; Herbert Y Lin
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

Review 2.  The type II transmembrane serine protease matriptase-2--identification, structural features, enzymology, expression pattern and potential roles.

Authors:  Andrew J Ramsay; Janet C Reid; Gloria Velasco; James P Quigley; John D Hooper
Journal:  Front Biosci       Date:  2008-01-01

3.  The serine protease TMPRSS6 is required to sense iron deficiency.

Authors:  Xin Du; Ellen She; Terri Gelbart; Jaroslav Truksa; Pauline Lee; Yu Xia; Kevin Khovananth; Suzanne Mudd; Navjiwan Mann; Eva Marie Y Moresco; Ernest Beutler; Bruce Beutler
Journal:  Science       Date:  2008-05-01       Impact factor: 47.728

4.  Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.

Authors:  Andrew J Sanders; Christian Parr; Tracey A Martin; Jane Lane; Malcolm D Mason; Wen G Jiang
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

5.  Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency.

Authors:  Flavia Guillem; Sarah Lawson; Caroline Kannengiesser; Mark Westerman; Carole Beaumont; Bernard Grandchamp
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

6.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).

Authors:  Karin E Finberg; Matthew M Heeney; Dean R Campagna; Yeşim Aydinok; Howard A Pearson; Kip R Hartman; Mary M Mayo; Stewart M Samuel; John J Strouse; Kyriacos Markianos; Nancy C Andrews; Mark D Fleming
Journal:  Nat Genet       Date:  2008-04-13       Impact factor: 38.330

7.  A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.

Authors:  Maria Antonietta Melis; Milena Cau; Rita Congiu; Gabriella Sole; Susanna Barella; Antonio Cao; Mark Westerman; Mario Cazzola; Renzo Galanello
Journal:  Haematologica       Date:  2008-07-04       Impact factor: 9.941

8.  Regulation of hepcidin in HepG2 and RINm5F cells.

Authors:  Evelyn Fein; Uta Merle; Robert Ehehalt; Thomas Herrmann; Hasan Kulaksiz
Journal:  Peptides       Date:  2007-02-02       Impact factor: 3.750

9.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

10.  Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients.

Authors:  Christian Parr; Andrew J Sanders; Gaynor Davies; Tracey Martin; Jane Lane; Malcolm D Mason; Robert E Mansel; Wen G Jiang
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

View more
  11 in total

1.  N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding.

Authors:  Jiang Jiang; Jianfeng Yang; Ping Feng; Bin Zuo; Ningzheng Dong; Qingyu Wu; Yang He
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

2.  The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.

Authors:  Peizhong Mao; Aaron M Wortham; Caroline A Enns; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2018-12-17       Impact factor: 5.157

3.  Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage.

Authors:  Caroline A Enns; Riffat Ahmed; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

4.  Low intracellular iron increases the stability of matriptase-2.

Authors:  Ningning Zhao; Christopher P Nizzi; Sheila A Anderson; Jiaohong Wang; Akiko Ueno; Hidekazu Tsukamoto; Richard S Eisenstein; Caroline A Enns; An-Sheng Zhang
Journal:  J Biol Chem       Date:  2014-12-30       Impact factor: 5.157

5.  Identification and characterization of a novel murine allele of Tmprss6.

Authors:  Thomas B Bartnikas; Andrea U Steinbicker; Dean R Campagna; Sherika Blevins; Lanette S Woodward; Carolina Herrera; Kenneth D Bloch; Monica J Justice; Mark D Fleming
Journal:  Haematologica       Date:  2013-01-08       Impact factor: 9.941

6.  Transcriptome analysis reveals TMPRSS6 isoforms with distinct functionalities.

Authors:  Sébastien P Dion; François Béliveau; Antoine Désilets; Mariana Gabriela Ghinet; Richard Leduc
Journal:  J Cell Mol Med       Date:  2018-02-14       Impact factor: 5.310

7.  Proteolytic cleavages in the extracellular domain of receptor tyrosine kinases by membrane-associated serine proteases.

Authors:  Li-Mei Chen; Karl X Chai
Journal:  Oncotarget       Date:  2017-04-10

8.  Functional diversity of TMPRSS6 isoforms and variants expressed in hepatocellular carcinoma cell lines.

Authors:  Sébastien P Dion; François Béliveau; Louis-Philippe Morency; Antoine Désilets; Rafaël Najmanovich; Richard Leduc
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

9.  Knockdown of TMPRSS3, a Transmembrane Serine Protease, Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells.

Authors:  Jun-Ying Wang; Xin Jin; Xiao-Feng Li
Journal:  Oncol Res       Date:  2017-04-12       Impact factor: 5.574

Review 10.  Secretases Related to Amyloid Precursor Protein Processing.

Authors:  Xiaoling Liu; Yan Liu; Shangrong Ji
Journal:  Membranes (Basel)       Date:  2021-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.